The IL-2 receptor complex: its structure, function, and target genes
about
Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptorMolecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytesMolecular cloning and characterization of a second subunit of the interleukin 1 receptor complexIdentification and cloning of a novel IL-15 binding protein that is structurally related to the alpha chain of the IL-2 receptorDefective human interleukin 2 receptor gamma chain in an atypical X chromosome-linked severe combined immunodeficiency with peripheral T cellsHuman immunodeficiency virus type 1 Tat upregulates interleukin-2 secretion in activated T cellsCloning of a type I cytokine receptor most related to the IL-2 receptor beta chainPotential role of phosphodiesterase 7 in human T cell function: comparative effects of two phosphodiesterase inhibitorsInterleukin-2 and its receptor complex (alpha, beta and gamma chains) in in situ and infiltrative human breast cancer: an immunohistochemical comparative studyNatural splicing of exon 2 of human interleukin-15 receptor alpha-chain mRNA results in a shortened form with a distinct pattern of expressionInterleukin-15 prevents mouse mast cell apoptosis through STAT6-mediated Bcl-xL expressionIdentification of an interleukin-15alpha receptor-binding site on human interleukin-15Direct cell surface modification with DNA for the capture of primary cells and the investigation of myotube formation on defined patterns.cDNA cloning of porcine interleukin-2 receptor-alpha gene.Construction, purification, and characterization of a chimeric TH1 antagonist.Phase I trial of ALT-801, an interleukin-2/T-cell receptor fusion protein targeting p53 (aa264-272)/HLA-A*0201 complex, in patients with advanced malignanciesThe liver plays a major role in clearance and destruction of blood trypomastigotes in Trypanosoma cruzi chronically infected mice.CD25 preselective anti-HIV vectors for improved HIV gene therapy.Therapeutic drug monitoring of immunosuppressant drugs.Soluble cytokine receptors: basic immunology and clinical applications.In vivo targeting of adoptively transferred T-cells with antibody- and cytokine-conjugated liposomesIL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25CpG-enhanced CD8+ T-cell responses to peptide immunization are severely inhibited by B cellsInterleukin 2 activates STAT5 transcription factor (mammary gland factor) and specific gene expression in T lymphocytes.Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivoTransgenic mice carrying the diphtheria toxin A chain gene under the control of the granzyme A promoter: expected depletion of cytotoxic cells and unexpected depletion of CD8 T cellsImmunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults.Critical role of the interleukin 2 (IL-2) receptor gamma-chain-associated Jak3 in the IL-2-induced c-fos and c-myc, but not bcl-2, gene inductionInterleukin-2 (IL-2) regulates the accessibility of the IL-2-responsive enhancer in the IL-2 receptor alpha gene to transcription factorsImproved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cellsInterleukin 4 signals through two related pathwaysActivated T cells secrete an alternatively spliced form of common γ-chain that inhibits cytokine signaling and exacerbates inflammationFocus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaRequirement of the expression of 3-phosphoglycerate dehydrogenase for traversing S phase in murine T lymphocytes following immobilized anti-CD3 activation.Activation of Stat5 by interleukin 2 requires a carboxyl-terminal region of the interleukin 2 receptor beta chain but is not essential for the proliferative signal transmission.Elevated circulating soluble interleukin-2 receptor in patients with chronic liver diseases is associated with non-classical monocytesProliferation assay amplification by IL-2 in model primary and recall antigen systems.Phenotypic knockout of the high-affinity human interleukin 2 receptor by intracellular single-chain antibodies against the alpha subunit of the receptor.Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivoChromatin condensation via the condensin II complex is required for peripheral T-cell quiescence
P2860
Q24312136-ED7D5EF4-FC10-4FD6-BA7A-DC08E0C5E72AQ24313200-E429EDFA-C9B5-4F0E-91B3-F31F4C2EFABFQ24321703-65188C23-D185-435B-B184-ED191ED801F9Q24323032-E514515A-19AF-411E-A022-56C762DE1E83Q24563583-1BD0F072-8300-4AB5-9E0E-CBDCB51B6E61Q24649124-ADE13DB7-884C-4A44-A133-6D3C833703E3Q24673607-847329C9-BD5B-4DE9-B9B8-339E9296711FQ24681386-43950481-F11B-44D1-AD29-E9D000FC0883Q24803779-B259E9CF-40BA-464F-9114-C6BC582F084EQ28144151-D5BFB9B8-4E93-4737-9D25-0D9559A310C7Q28190211-5ABD476A-309C-4E52-BAC7-03DDAB402B5CQ28252347-BEC5468F-A464-4BEF-A6CD-725FF772C8C4Q30492908-BBE08E2B-CAF2-4D44-85E8-857E7193D2B2Q32146649-CE55FCD7-65A7-4D39-AF80-99F08F15044EQ33244262-D1A3395E-E26A-414F-BF18-5A3F3278239EQ33397618-B637C5B0-A8F8-4EEA-8D12-3B124A425004Q33522196-C6FD7F47-1F94-49DE-9D59-6BAFEB1A5C3EQ33586299-15C71EEE-B599-41C0-B67E-BA8C28E63EBEQ33610775-1D81CCDE-3455-418B-8DEF-F4CBA39ABC2EQ33688222-9180557B-C0DF-4DC3-9EE3-73E21A6B7709Q33716478-6F0CB9E9-EE7E-4D64-BC2B-7758E5681CBCQ33719745-A7B65328-CC3A-42A2-AD7D-D86FF52BCA9AQ33765164-0E108415-3E0E-48DA-A072-9DB1477F7001Q33801733-DCFA2E22-2AF1-4A6A-8E2A-5426F623992DQ33822233-FE54569F-4FE0-437E-A3D4-F7334473C34CQ33825521-8C8DEA07-4012-4E71-BA7A-1ECC1B2BAA3EQ33856329-351639B0-4622-4830-A9A3-9D80EDB8D94FQ33921686-383BD43C-C309-479E-9B3C-4E8EC462364EQ33957692-7FC85799-7794-4EBB-8516-E1203DC83158Q33977597-2A2BD01F-4334-435D-A58C-F2B199E7B20AQ34020774-E51C3CC1-A279-4E6C-9941-7BA9D1451280Q34083758-F5E1497F-1B43-4BAB-B798-E17E6F01904CQ34111789-DF56857F-15F3-458D-A054-89E37AE648BDQ34213515-58D598CB-4ACC-41D4-AE0C-8EAD022D1DF6Q34229092-7B097BAA-947D-4207-8018-9AAC2AC8B594Q34244205-3BF2944A-1CB6-48DD-AAE2-4083E02F1915Q34309984-057D5078-5B70-4808-B3FC-81718108BA39Q34416149-F72AD12F-CAF4-449D-9CCC-8902257087ECQ34506140-77FFC0D8-11FA-4091-992F-8EF83CEE634FQ34513296-E00F2681-5E9F-4EAE-B8B0-0CC9A8C345F7
P2860
The IL-2 receptor complex: its structure, function, and target genes
description
1993 nî lūn-bûn
@nan
1993 թուականին հրատարակուած գիտական յօդուած
@hyw
1993 թվականին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
The IL-2 receptor complex: its structure, function, and target genes
@ast
The IL-2 receptor complex: its structure, function, and target genes
@en
The IL-2 receptor complex: its structure, function, and target genes
@en-gb
The IL-2 receptor complex: its structure, function, and target genes
@nl
type
label
The IL-2 receptor complex: its structure, function, and target genes
@ast
The IL-2 receptor complex: its structure, function, and target genes
@en
The IL-2 receptor complex: its structure, function, and target genes
@en-gb
The IL-2 receptor complex: its structure, function, and target genes
@nl
prefLabel
The IL-2 receptor complex: its structure, function, and target genes
@ast
The IL-2 receptor complex: its structure, function, and target genes
@en
The IL-2 receptor complex: its structure, function, and target genes
@en-gb
The IL-2 receptor complex: its structure, function, and target genes
@nl
P2093
P3181
P1476
The IL-2 receptor complex: its structure, function, and target genes
@en
P2093
P304
P3181
P356
10.1146/ANNUREV.IY.11.040193.001333
P407
P577
1993-01-01T00:00:00Z